RAFLF (Raffles Medical Group) 3-Year Share Buyback Ratio: 0.30% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RAFLF Raffles Medical Group Ltd RAFLF
57 GF Score
Price $0.67
GF Value $0.81
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Raffles Medical Group 3-Year Share Buyback Ratio?

Raffles Medical Group RAFLF 57 3-Year Share Buyback Ratio is 0.30 as of Jun. 2026. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.81 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 444 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 81.76% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Raffles Medical Group's current 3-Year Share Buyback Ratio was 0.30%.

The historical rank and industry rank for Raffles Medical Group's 3-Year Share Buyback Ratio or its related term are showing as below:

RAFLF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -9.6   Med: -1.5   Max: 0.3
Current: 0.3

During the past 13 years, Raffles Medical Group's highest 3-Year Share Buyback Ratio was 0.30%. The lowest was -9.60%. And the median was -1.50%.

RAFLF's 3-Year Share Buyback Ratio is ranked better than
81.76% of 444 companies
in the Healthcare Providers & Services industry
Industry Median: -1.75 vs RAFLF: 0.30

Raffles Medical Group (OTCPK:RAFLF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.


Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.


Raffles Medical Group 3-Year Share Buyback Ratio Related Terms


RAFLF vs HCA, THC, EHC: 3-Year Share Buyback Ratio Comparison

For the Medical Care Facilities subindustry, Raffles Medical Group's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raffles Medical Group 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Raffles Medical Group's 3-Year Share Buyback Ratio falls into.


RAFLF
57GF Score
Raffles Medical Group Ltd RAFLF
3-Year Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raffles Medical Group 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of 0.30 mean?
Raffles Medical Group (RAFLF) has a 3-Year Share Buyback Ratio of 0.30 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Raffles Medical Group and its competitors. According to the industry distribution chart, Raffles Medical Group ranks #81 out of 444 companies in the Healthcare Providers & Services industry, placing it in the top 18.2%.
Is Raffles Medical Group's 3-Year Share Buyback Ratio too high?
Raffles Medical Group's current 3-Year Share Buyback Ratio is 0.30. Based on the distribution chart, Raffles Medical Group ranks #81 out of 444 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's 3-Year Share Buyback Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #81 out of 444 companies for 3-Year Share Buyback Ratio. This places Raffles Medical Group in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Raffles Medical Group and its competitors. Raffles Medical Group's current 3-Year Share Buyback Ratio is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.81, compared to a current price of $0.67 — trading 17.3% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.30. Raffles Medical Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current 3-Year Share Buyback Ratio is 0.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raffles Medical Group (RAFLF) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued. The current stock price of $0.67 is trading 17.3% below its estimated GF Value™ of $0.81. GuruFocus considers Raffles Medical Group to be Modestly Undervalued.

Key valuation signals for RAFLF:

  • 3-Year Share Buyback Ratio: 0.30
  • GF Value™: $0.81 vs. price of $0.67 (17.3% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raffles Medical Group Business Description

Other Exchanges BSL:Singapore
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score

Get the complete analysis for RAFLF

3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price
$0.81
GF Value